New York State Assembly

 
•  Summary 
 
•  Actions 
 
•  Committee Votes 
 
•  Floor Votes 
 
•  Memo 
 
•  Text 
 
•  LFIN 
 
•  Chamber Video/Transcript 

A01384 Summary:

A01384 Actions:

A01384 Committee Votes:

Committee:HEALTH   Chair:Gottfried      
DATE:06/06/2017AYE/NAY:26/0  Action: Favorable refer to committee Codes        
Gottfried
Aye
Raia
Aye
Schimminger
Aye
McDonough
Aye
Galef
Aye
Ra
Aye
Dinowitz
Aye
Walter
Aye
Cahill
Aye
Garbarino
Aye
Paulin
Aye
Byrne
Aye
Cymbrowitz
Aye
Norris
Aye
Gunther
Aye
Rosenthal
Aye
Hevesi
Aye
Lavine
Aye
Titone
Aye
Mayer
Aye
Jaffee
Aye
Steck
Aye
Abinanti
Aye
Braunstein
Aye
Kim
Aye
Solages
Aye

Committee:CODES   Chair:Lentol      
DATE:06/06/2017AYE/NAY:22/0  Action: Favorable refer to committee Rules        
Lentol
Aye
Graf
Aye
Schimminger
Aye
Giglio
Aye
Weinstein
Aye
McKevitt
Aye
Pretlow
Aye
Montesano
Aye
Cook
Aye
Ra
Aye
Cymbrowitz
Aye
Morinello
Aye
Titus
Aye
O'Donnell
Aye
Lavine
Aye
Perry
Aye
Zebrowski
Aye
Abinanti
Aye
Weprin
Aye
Mosley
Aye
Hevesi
Aye
Fahy
Aye

Committee:RULES   Chair:Heastie      
DATE:06/07/2017AYE/NAY:28/0  Action: Favorable         
Heastie
Aye
Kolb
Excused
Gottfried
Aye
Oaks
Aye
Lentol
Aye
Butler
Aye
Farrell
Aye
Crouch
Aye
Gantt
Aye
Finch
Aye
Nolan
Aye
Barclay
Aye
Weinstein
Aye
Raia
Aye
Hooper
Excused
Hawley
Aye
Ortiz
Aye
Pretlow
Aye
Cook
Aye
Glick
Aye
Morelle
Aye
Aubry
Aye
Englebright
Aye
Dinowitz
Aye
Colton
Aye
Magnarelli
Excused
Perry
Aye
Galef
Aye
Paulin
Aye
Titus
Aye
Peoples-Stokes
Aye

A01384 Floor Votes:

A01384 Text:

 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          1384
 
                               2017-2018 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 12, 2017
                                       ___________
 
        Introduced  by  M. of A. ZEBROWSKI, CUSICK, ORTIZ, GALEF, COLTON, JENNE,
          BRINDISI, JAFFEE, TITUS, GUNTHER, COOK, TITONE,  MAGNARELLI,  BARRETT,
          STIRPE, BUCHWALD, LOPEZ, MOSLEY, HUNTER -- Multi-Sponsored by -- M. of
          A.  BARCLAY, CROUCH, DINOWITZ, FINCH, HAWLEY, MAGEE, McKEVITT, MONTES-
          ANO,  PALMESANO,  PEOPLES-STOKES, PERRY, RODRIGUEZ, STECK -- read once
          and referred to the Committee on Health
 
        AN ACT to amend the public health law, in relation to adding  cannabimi-
          metic agents to the schedule of controlled substances
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Schedule I of section 3306 of  the  public  health  law  is
     2  amended by adding a new subdivision (g) to read as follows:
     3    (g)  (1) Cannabimimetic agents. Unless specifically exempted or unless
     4  listed in another schedule, any material, compound, mixture, or prepara-
     5  tion that is not approved by the federal food  and  drug  administration
     6  (FDA)  which  contains  any  quantity of cannabimimetic agents, or which
     7  contains their salts, isomers, and salts of isomers whenever the  exist-
     8  ence of such salts, isomers, and salts of isomers is possible within the
     9  specific chemical designation.
    10    (2)  As  used  in  this  subdivision, the term "cannabimimetic agents"
    11  means any substance that is a cannabinoid receptor type 1 (CB1 receptor)
    12  agonist as demonstrated by binding studies and functional assays  within
    13  any of the following structural classes:
    14    (i)  2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position
    15  of the phenolic ring by alkyl or alkenyl, whether or not substituted  on
    16  the cyclohexyl ring to any extent.
    17    (ii)  3-(1-naphthoyl)indole  or 3-(1-naphthylmethane)indole by substi-
    18  tution at the nitrogen atom of the indole ring, whether or  not  further
    19  substituted on the indole ring to any extent, whether or not substituted
    20  on the naphthoyl or naphthyl ring to any extent.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD04439-01-7
        A. 1384                             2
 
     1    (iii)  3-(1-naphthoyl)pyrrole  by substitution at the nitrogen atom of
     2  the pyrrole ring, whether or not further substituted in the pyrrole ring
     3  to any extent, whether or not substituted on the naphthoyl ring  to  any
     4  extent.
     5    (iv)  1-(1-naphthylmethylene)indene  by substitution of the 3-position
     6  of the indene ring, whether or not further  substituted  in  the  indene
     7  ring  to  any extent, whether or not substituted on the naphthyl ring to
     8  any extent.
     9    (v) 3-phenylacetylindole or 3-benzoylindole  by  substitution  at  the
    10  nitrogen  atom of the indole ring, whether or not further substituted in
    11  the indole ring to any extent, whether or not substituted on the  phenyl
    12  ring to any extent.
    13    (3) Such term includes:
    14    (i)      5-(1,1-dimethylheptyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol
    15  (CP-47,497);
    16    (ii)      5-(1,1-dimethyloctyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol
    17  (cannabicyclohexanol or CP-47,497 C8-homolog);
    18    (iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);
    19    (iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);
    20    (v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);
    21    (vi) 1-{2-(4-morpholinyl)ethyl}-3-(1-naphthoyl)indole (JWH-200);
    22    (vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);
    23    (viii) 1-pentyl-3-{1-(4-methoxynaphthoyl)}indole (JWH-081);
    24    (ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);
    25    (x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);
    26    (xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);
    27    (xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);
    28    (xiii) 1-pentyl-3-{(4-methoxy)-benzoyl}indole (SR-19 and RCS-4);
    29    (xiv)   1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole  (SR-18  and
    30  RCS-8); and
    31    (xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).
    32    § 2. This act shall take effect on the ninetieth day  after  it  shall
    33  have become a law.